How Pur­due's $272M ad­dic­tion pay­out fund­ed a new home for its dis­card­ed non-opi­oid re­search

13 hours ago
Pharma
In Focus

#JPM23: This is how we cure can­cer

Yesterday

Chat­G­PT and gen­er­a­tive AI land in phar­ma mar­ket­ing with sense of awe — and plen­ty of cau­tion

Yesterday
Pharma
Marketing

Drag­on­fly chief: Bris­tol My­ers shouldn’t blame IL-12’s clin­i­cal per­for­mance for de­ci­sion to scrap the deal — eco­nom­ics played a key role

Yesterday
Deals
Bioregnum

A long­time track­er on phar­ma R&D pro­duc­tiv­i­ty takes a post-pan­dem­ic plunge back to a bleak re­al­i­ty

2 days ago
Bioregnum
R&D

Up­dat­ed: R&D tur­bu­lence at Bris­tol My­ers now in­cludes the end of a $650M al­liance and the de­par­ture of a top re­search cham­pi­on

2 days ago
Bioregnum

J&J’s Janssen lays off em­ploy­ees at Penn­syl­va­nia, New Jer­sey sites

6 days ago
People
Pharma

Parthenon Ther­a­peu­tics CEO ex­its weeks af­ter co-founder leaves

6 days ago
People
Startups

#JPM23: Is 2023 go­ing to be a bet­ter year for biotech deal­mak­ing?

6 days ago

Q&A: No­vo Nordisk mar­ket­ing chief aims to change the con­ver­sa­tion around obe­si­ty, even as so­ci­ety has its own plans

Last week
Pharma
Marketing

No­var­tis' Xo­lair suc­ces­sor hit by an­oth­er PhI­II axe, but food al­ler­gy study con­tin­ues

Last week
R&D
Pharma

#JPM23: Reg­u­la­to­ry un­cer­tain­ty? What about M&A? Da­ta rule? Alessan­dro Masel­li and John Car­roll take out their crys­tal balls

Last week

Am­gen lays off about 300 work­ers, cit­ing 'in­dus­try head­wind­s'

Last week
People
Pharma

Pfiz­er lays off em­ploy­ees at Cal­i­for­nia and Con­necti­cut sites

Last week
People
Pharma

#JPM23: BeiGene CEO John Oyler on the com­pa­ny's big am­bi­tions

Last week

#JPM23: What's re­al­ly dri­ving the cost of health­care and drugs in 2023?

Last week

#JPM23: Did the IRA kill that drug?

2 weeks ago

Pi­o­neer­ing biotech icon George Scan­gos hands in his re­tire­ment pa­pers — and this time it’s for re­al

2 weeks ago
People
Bioregnum

A stem cell pi­o­neer sent an ex­per­i­ment in­to space. Pa­tients are the next fron­tier

2 weeks ago
People
Cell/Gene Tx

#JPM23: Fire­side chat with Ei­sai's Ivan Che­ung

3 weeks ago
R&D

#JPM23: Fire­side chat with Bar­ry Greene: 'There's no straight line to suc­cess'

3 weeks ago

#JPM23: When will the IPO win­dow open? What terms are star­tups get­ting? Here's what to ex­pect from cap­i­tal mar­kets this year

3 weeks ago

What’s with Bris­tol My­ers’ R&D job cuts in New Jer­sey? They’re not say­ing much

3 weeks ago
People
Bioregnum

Scoop: Just months af­ter Sanofi AI deal, Atom­wise laid off 30% of staffers amid 's­trate­gic shift'

3 weeks ago
People
1234 Next page Last page